Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Combined inhibition of lysine-specific demethylase 1 and kinase signaling as a preclinical treatment strategy in glioblastoma

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf246Source: DataRank Database

Combined inhibition of lysine-specific demethylase 1 and kinase signaling as a preclinical treatment strategy in glioblastoma is a research paper published in Neuro-Oncology Advances (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

cellosaurus doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.00)OA: goldTopics (14)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Deokhwa Nam,Faith A Hernandez,Kareena H. Patel,Alaina Poche,Huaxian Ma ORCID

Live enrichment

PubMed:41497449 PMC:PMC12768500 OpenAlex:https://openalex.org/W4416428210

National Institutes of Health

Grant: R21 NS093387

National Institutes of Health

Grant: P50 CA127001

National Institutes of Health

Grant: TL1 TR003169

National Institutes of Health

Grant: R61/R33NS111058

National Institutes of Health

Grant: P30 CA016672

National Institutes of Health

Grant: NS106173-01A1

FWCI

0.00

Citation Percentile

0.2%

goldLicense: cc-by

journalhttps://doi.org/10.1093/noajnl/vdaf246

publisherhttps://doi.org/10.1093/noajnl/vdaf246

publisherhttps://academic.oup.com/noa/advance-article-pdf/doi/10.1093/noajnl/vdaf246/65415589/vdaf246.pdf

publisherhttps://academic.oup.com/noa/article-pdf/7/1/vdaf246/65415589/vdaf246.pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41497449

Fields of Study

Epigenetics and DNA MethylationFibroblast Growth Factor ResearchHistone Deacetylase Inhibitors Research

Keywords

GlioblastomaDemethylaseKinaseSignal transductionTyrosine kinaseAcquired resistanceEGFR inhibitorsKinase SignalingGlioblastoma Stem CellOsimertinibLysine Specific Demethylase-1

Combined inhibition of lysine-specific demethylase 1 and kinase signaling as a preclinical treatment strategy in glioblastoma

FAIR Checklist

Authors (17)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)